Long-term efficacy and safety of Oxcarbazepine (OXC) in clinical practice were evaluated on 160 epileptic patients, over a mean period of two years and eight months. Both patients received OXC in monotherapy and in add-on and showed either maintenance (75.65%) or an improvement (21.25%) in seizures control. Overall, Oxcarbazepine was well tolerated, with 9.03% of patients experiencing adverse events similar to those previously reported.
Efficacia a lungo termine del trattamento con Oxcarbazepina in monoterapia e in add-on: L'esperienza clinica nel Triveneto dopo un anno di follow-up
PAULETTO, GIADA;PRIVATO, Fiorenza;BERGONZI, Paolo;DOLSO, Pierluigi;GIGLI, Gian Luigi;PANICO, ANNA CLARA;SERENA, MARINA;
2004-01-01
Abstract
Long-term efficacy and safety of Oxcarbazepine (OXC) in clinical practice were evaluated on 160 epileptic patients, over a mean period of two years and eight months. Both patients received OXC in monotherapy and in add-on and showed either maintenance (75.65%) or an improvement (21.25%) in seizures control. Overall, Oxcarbazepine was well tolerated, with 9.03% of patients experiencing adverse events similar to those previously reported.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
